Don't forget that this is also the initial number. Everything is up for negotiation. They will be licensing all their products. They are not a BP company in the making. It's why Krishna is back in the lab full time. They will get a percentage of the sales plus the license fee. BP will get the big dollars but it keeps C with a very high liquidity and Krishna working on the next money maker. REGN style. Even one, two, three drugs is all they need to be a blockbuster company but they have way more than that when one considers the different applications with each drug and the ones they don't even have on the public's radar yet. Get one application of K, end up with 6?
B alone has so many applications they could only need this drug alone to be a monster.

Someone was wild trying to know the pps down but someone else was there to scoop up the shares. Would have been sweet to have broken even.